TD Cowen analyst Yaron Werber maintains $Alector (ALEC.US)$ with a buy rating.
According to TipRanks data, the analyst has a success rate of 55.2% and a total average return of 12.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Alector (ALEC.US)$'s main analysts recently are as follows:
Following the Phase 2 INVOKE-2 study, where AL002 did not show effectiveness in slowing Alzheimer's progression or impacting disease biomarkers, analysts have moderated their outlook. Potential remains noted for latozinemab, though the focus may shift towards other opportunities within their coverage, pending late-stage data in frontotemporal dementia expected around late 2025 to early 2026.
The TREM2 activation showed minimal impact in treating Alzheimer's disease, which poses challenges for the approach of using genome-wide association studies-driven medicine. Additionally, there may be a need to reassess the mechanism of ARIA-E.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
TD Cowen分析師Yaron Werber維持$Alector (ALEC.US)$買入評級。
根據TipRanks數據顯示，該分析師近一年總勝率為55.2%，總平均回報率為12.1%。
此外，綜合報道，$Alector (ALEC.US)$近期主要分析師觀點如下：
在 INVOKE-2 第 2 期研究中，AL002 並未顯示出減緩阿爾茨海默氏症進展或影響疾病生物標誌物的有效性，此後，分析師們調整了他們的展望。拉託津單抗的潛力仍然顯而易見，儘管焦點可能會轉移到其覆蓋範圍內的其他機會上，但尚待預計在2025年底至2026年初左右獲得額頜癡呆的後期數據。
TREM2 的激活對治療阿爾茨海默氏病的影響微乎其微，這給使用全基因組關聯研究驅動的藥物的方法帶來了挑戰。此外，可能需要重新評估ARIA-E的機制。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
